IRVINE, Calif., Oct. 5, 2005 (PRIMEZONE) -- The informational report "Innovations in Biotechnology" has been made available free of charge at www.SmallCapSentinel.com and will address biotechnologies, expiring patent issues, market leaders and emergent companies.
"It's no secret that expiring patents are an enormous concern for major drug companies like Merck Co. Inc (NYSE: MRK), Pfizer Inc. (NYSE: PFE), and Astrazeneca PLC ADS (NYSE: AZN), especially considering the lawsuits drug companies could face over questionable drugs once readily sold in the marketplace," stated SmallCap Sentinel analyst D.R. Clark. "The expiration of patents combined with the threat of litigation should mean that companies- and the health sector at large- should be turning an eager eye to innovation in health and related technologies."
The report will also address Callisto Pharmaceuticals (AMEX: KAL), a biopharmaceutical company committed to developing innovative anti-cancer drugs to treat blood cancers and related diseases, including acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML), relapsed or refractory multiple myeloma, and osteolytic disease. Callisto also has drugs in pre-clinical development for gastrointestinal inflammation, as well as for protection against the potential bio-warfare agents, staphylococcus and streptococcus.
A detailed informational report regarding Callisto Pharmaceuticals is available free to the public at the following link:
http://www.trilogy-capital.com/kal_summary.aspx
Individuals may also register to receive future reports at:
http://stockupticks.com/register.html
SmallCap Sentinel and StockUpTicks.com are publications of financial courier Market Pathways, a twenty-two year old full service financial relations firm which offers information on specific public companies to interested investors. To have your company featured in StockUpTicks or SmallCap Sentinel please use the contact information below.
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that will affect results. SmallCapSentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy or offer to sell securities but is rather a paid advertisement provided for information purposes only and shouldn't be used as the basis for investment decisions. MP is not an investment advisor and this report is not investment advice. MP has been paid fifteen hundred dollars by Callisto for this report and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.